Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Kisspeptin-10

KP-10, Metastin (45-54), Kisspeptin-10 (human), KiSS-1

Quick Stats
Studies 877
Trials 47
Score 2
2018 pubmed 20 citations

Kisspeptin Receptor GPR54 Promotes Adipocyte Differentiation and Fat Accumulation in Mice.

Wang. Tongtong T; Cui. Xueqin X; Xie. Ling L; Xing. Roumei R; You. Panpan P; Zhao. Yongliang Y; Yang. Yiqing Y; Xu. Yongqian Y; Zeng. Li L; Chen. Huaqing H; Liu. Mingyao M

Key Findings

  • Kisspeptin‑10 (Kp‑10) speeds up the conversion of precursor cells into fat cells and boosts triglyceride production in vitro.
  • Mice without the GPR54 receptor (Gpr54‑/-) gain weight more slowly on a high‑fat diet, have smaller adipocytes, lower liver fat, and reduced inflammatory macrophages in fat tissue.
  • Loss of GPR54 reduces activation of the ERK/MAP‑kinase pathway and lowers expression of lipid‑synthesis genes such as PPARÎł, ACC1, ADIPO, and FAS.

Practical Outcomes

  • For biohackers focused on leanness, this suggests that activating the kisspeptin‑GPR54 axis may be counterproductive, as it promotes fat storage. Inhibiting this pathway (e.g., with antagonists or lifestyle factors that lower kisspeptin signaling) could be explored as a strategy to blunt adipogenesis, but no safe, human‑ready protocol exists yet. The findings are mainly mechanistic and not a direct recommendation for supplementation or dosing.

Summary

The study shows that the kisspeptin‑10 peptide, acting through its receptor GPR54, pushes stem cells and fat cells to become more fat‑filled and makes mice gain weight faster on a high‑fat diet. Mice lacking the receptor stay leaner, have smaller fat cells, and less inflammation in their fat tissue.

Abstract

GPR54, Kisspeptin-1 receptor (KISS1R), a member of rhodopsin family, plays a critical role in puberty development and has been proposed to be involved in regulation of energy metabolism. This study aims to explore the function of GPR54 in adipogenesis, lipid metabolism, and obesity in addition to its effect through hormones. Results showed that when fed a high-fat diet, the weight growth of castrated or ovariectomized <i>Gpr54</i><sup>-/-</sup> mice was significantly slower than that of WT control, together with a lower triglyceride concentration. The ratio of white adipose tissue was lower, and average size of adipocytes was smaller in <i>Gpr54</i><sup>-/-</sup> mice. Meanwhile, there were less adipose tissue macrophages (ATMs), especially pro-inflammatory macrophages. Expression of inflammatory related genes also indicated that inflammatory response caused by obesity was not as drastic in <i>Gpr54</i><sup>-/-</sup> mice as in WT mice. Liver triglyceride in <i>Gpr54</i><sup>-/-</sup> mice was reduced, especially in female mice. On the other hand, oil drop formation was accelerated when hepatocytes were stimulated by kisspeptin-10 (Kp-10). Primary mesenchymal stem cells (MSCs) of <i>Gpr54</i><sup>-/-</sup> mice were less likely to differentiate into adipocytes. When stimulated by Kp-10, 3T3-L1 cell differentiation into adipocytes was accelerated and triglyceride synthesis was significantly promoted. These data indicated that GPR54 could affect obesity development by promoting adipocyte differentiation and triglyceride accumulation. To further elucidate the mechanism, genes related to lipid metabolism were analyzed. The expression of genes involved in lipid synthesis including PPAR&#x3b3;, ACC1, ADIPO, and FAS was significantly changed in <i>Gpr54</i><sup>-/-</sup> mice. Among them PPAR&#x3b3; which also participate in adipocyte differentiation displayed a marked reduction. Moreover, phosphorylation of ERK, which involved in GPR54 signaling, was significantly decreased in <i>Gpr54</i><sup>-/-</sup> mice, suggesting that GPR54 may promote lipid synthesis and obesity development by activating MAP kinase pathway. Therefore, in addition to the involvement in hormone regulation, our study demonstrated that GPR54 directly participates in obesity development by promoting adipocyte differentiation and fat accumulation. This provided evidence of involvement of GPR54 in lipid metabolism, and revealed new potentials for the identification and development of novel drug targets for metabolic diseases.

Study Information

Provider

pubmed

Year

2018

Date

2018-03-13T00:00:00.000Z

DOI

10.3389/fphys.2018.00209

Citations

20

References

48